Light (0.01-10 g/day) | Light to moderate (10.1-20 g/day) | Moderate (20.1-40 g/day) | Moderate to high (40.1-60 g/day) | High (60.1-120 g/day) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | I2 | RR (95% CI) | N | I2 | RR (95% CI) | N | I2 | RR (95% CI) | N | I2 | RR (95% CI) | N | I2 | RR (95% CI) | |
Men | |||||||||||||||
Total | 1 | – | 0.54 (0.28–1.04) | 4 | 0 | 0.68 (0.57–0.81) | 4 | 16 | 0.72 (0.58–0.90) | 3 | 0 | 1.02 (0.84–1.23) | 2 | 89 | 1.32 (0.61–2.86) |
Comorbidity = 0 | – | – | – | 1 | – | 0.54 (0.27–1.08) | 1 | – | 0.40 (0.19–0.84) | – | – | – | – | – | – |
Comorbidity = 1–2 | – | – | – | 1 | – | 0.64 (0.51–0.80) | 1 | – | 0.71 (0.57–0.88) | 1 | – | 0.99 (0.79–1.24) | 1 | – | 0.91 (0.69–1.20) |
Comorbidity = 3–4 | – | – | – | 2 | 0 | 0.80 (0.58–1.11) | 2 | 0 | 0.85 (0.61–1.18) | 2 | 0 | 1.09 (0.76–1.56) | 1 | – | 2.00 (1.30–3.08) |
Age ≤ 40 | 1 | – | 0.26 (0.05–1.35) | 1 | – | 0.45 (0.08–2.53) | 1 | – | 0.37 (0.06–2.28) | – | – | – | |||
Age 41–65 | 1 | – | 0.54 (0.28–1.04) | 3 | 0 | 0.66 (0.54–0.80) | 3 | 44 | 0.71 (0.52–0.96) | 2 | 0 | 1.04 (0.85–1.26) | – | – | – |
Age ≤ 65 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Age ≤ 20 | – | – | – | 1 | – | 0.80 (0.51–1.25) | 1 | – | 0.74 (0.41–1.34) | 1 | – | 0.79 (0.37–1.69) | – | – | – |
Women | |||||||||||||||
Total | 1 | – | 0.67 (0.31–1.45) | 1 | – | 0.73 (0.34–1.57) | – | – | – | – | – | – | – | – | – |
Comorbidity = 0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Comorbidity = 1–2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Comorbidity = 3–4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Age ≤ 40 | 1 | – | 0.14 (0.05–0.39) | 1 | – | 0.50 (0.20–1.25) | – | – | – | – | – | – | – | – | – |
Age 41–65 | 1 | – | 0.67 (0.31–1.45) | 1 | – | 0.73 (0.34–1.57) | – | – | – | – | – | – | – | – | – |
Age ≥ 65 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Age ≤ 20 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Men + Women | |||||||||||||||
Total | 1 | – | 0.97 (0.87–1.08) | 2 | 0 | 0.94 (0.76–1.17) | 3 | 50 | 0.86 (0.61–1.22) | 1 | – | 1.16 (0.66–2.04) | 2 | 0 | 0.94 (0.44–2.00) |
Comorbidity = 0 | – | – | – | 1 | – | 1.47 (0.59–3.66) | 2 | 67 | 0.88 (0.38–2.01) | – | – | – | – | – | – |
Comorbidity = 1–2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Comorbidity = 3–4 | – | – | – | 1 | – | 0.92 (0.74–1.14) | 1 | – | 0.92 (0.76–1.11) | – | – | – | – | – | – |
Age ≤ 40 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Age 41–65 | – | – | – | – | – | – | 1 | – | 0.62 (0.40–0.96) | – | – | – | 1 | – | 1.42 (0.41–4.92) |
Age ≤ 65 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Age ≤ 20 | – | – | – | – | – | – | 2 | 7 | 0.96 (0.74–1.23) | – | – | – | 1 | – | 0.73 (0.28–1.90) |